Latest filing published 06 Jan 2026 for BICYCLE THERAPEUTICS plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -15.8%Entry US$80.61 · Close at T+365 US$67.84
- +36.8%Entry US$62.13 · Close at T+365 US$85.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Herve Hoppenot: trading record in brief
Herve Hoppenot, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Incyte Corp and BICYCLE THERAPEUTICS plc. The record holds 62 filings, for trades running from 13 January 2014 to 2 January 2026.
Market trades split into 2 purchases (€1.6M) and 6 sales (€44.3M). The net balance comes to €42.7M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 50 share grants and 4 option exercises.
Most recently, on 6 January 2026, the filings show a share grant in BICYCLE THERAPEUTICS plc. The last insider purchase was made public on 23 February 2021, 2,084 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Herve Hoppenot
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,032 shares0Ordinary SharesSEC:0001596492-26-000002:0
- 2,843 shares@ US$96.700.9% of flowCommon StockSEC:0001596492-25-000010:0
- 187,500 shares@ US$105.4668.8% of flowCommon StockSEC:0001596492-25-000008:0
- 12,500 shares0Ordinary SharesSEC:0001415889-25-024100:0
- 4,713 shares@ US$68.250.3% of flowCommon StockSEC:0000879169-25-000079:1
- 4,961 shares@ US$69.981.2% of flowCommon StockSEC:0000879169-25-000079:0
- 42,769 shares@ US$68.179.9% of flowCommon StockSEC:0000879169-25-000071:0
- 6,016 shares0Common StockSEC:0001628280-25-033513:0
- 66,899 shares0Common StockSEC:0001628280-25-016570:0
- 4,961 shares@ US$64.250.3% of flowCommon StockSEC:0000879169-24-000133:1
- 41,025 shares0Common StockSEC:0000879169-24-000133:0
- 41,723 shares@ US$59.029.2% of flowCommon StockSEC:0000879169-24-000116:0
- 41,577 shares0Common StockSEC:0000879169-24-000060:0
- 43,184 shares0Common StockSEC:0001209191-23-042547:0
- 43,467 shares@ US$62.089.9% of flowCommon StockSEC:0001209191-23-041510:0
- 29,196 shares0Common StockSEC:0001209191-23-004564:0
- 21,174 shares@ US$79.252.0% of flowCommon StockSEC:0001209191-22-041071:1
- 60,433 shares0Common StockSEC:0001209191-22-041071:0
- 13,279 shares0Common StockSEC:0001209191-21-066406:1
- 2,227 shares0Common StockSEC:0001209191-21-066406:0
- 16,089 shares@ US$83.581.4% of flowCommon StockSEC:0001209191-21-045789:1
- 1,562 shares@ US$83.340.1% of flowCommon StockSEC:0001209191-21-045789:2
- 44,264 shares0Common StockSEC:0001209191-21-045789:0
- 12,925 shares@ US$77.371.0% of flowCommon StockSEC:0001209191-21-013261:0Canonical exit: 24 May 2021 (T+90)
- 7,225 shares0Common StockSEC:0001209191-20-059104:0
25 of 62 declarations
